Latest News for: cytokine receptor

Edit

Ulcerative Colitis Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical trials, Medication, Therapies, Prevalence and ...

GetNews 27 Mar 2025
TREMFYA® is the first and only approved fully-human, dual-acting monoclonal antibody that blocks IL-23 while also binding to CD64, a receptor on cells that produce IL-23. IL-23 is a cytokine ...
Edit

NK Cell Therapy Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, IND, NDA Approval, ...

GetNews 17 Mar 2025
For instance, integrating cytokine-induced memory-like NK cells with chimeric antigen receptor (CAR) or BiKE expression has demonstrated enhanced responses ... In contrast, T-cell receptor ...
Edit

Ankylosing spondylitis Market Set to Grow Substantially Through 2034, DelveInsight Projects | Kinevant Sciences, MoonLake ...

GetNews 17 Mar 2025
Some of the key facts of the Ankylosing spondylitis Market Report. ... With best-in-class potential, NEU-111 reduces signaling through multiple cytokine receptors, including those for interleukin (IL)-12, IL-23, and interferon (IFN) ... KIN-1901 ... Sonelokimab.
Edit

Bullous Pemphigoid Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Therapies, MOA, ROA, ...

GetNews 12 Mar 2025
Bullous Pemphigoid Drugs Uptake FASENRA (benralizumab) is a monoclonal antibody that binds directly to IL-5 receptor alpha on eosinophils ... DUPIXENT (dupilumab) is a monoclonal antibody targeting the chain of the interleukin (IL)-4 receptor.
  • 1
×